Global Antibody Drug Conjugates Contract Manufacturing Market Report 2024

Antibody Drug Conjugates Contract Manufacturing Global Market Report 2024 – By Type (Immunoglobulin G1 (Igg–, Immunoglobulin G4 (Igg,), By Linker (Cleavable Linker, Non-Cleavable Linker), By Condition (Myeloma, Lymphoma, Breast Cancer, Other Conditions), By Phase (Clinical, Commercial) – Market Size, Trends, And Global Forecast 2024-2033

Antibody Drug Conjugates Contract Manufacturing Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Global Antibody Drug Conjugates Contract Manufacturing Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN

Antibody Drug Conjugates Contract Manufacturing Market Definition

Antibody-drug conjugates (ADC) contract manufacturing refers to the outsourced production services provided by specialized contract development and manufacturing organizations (CDMOs) to create antibody-drug conjugates. ADCs are complex biopharmaceuticals that combine an antibody with a cytotoxic drug, designed to target and destroy specific cancer cells while minimizing damage to healthy cells.

The main types of antibody-drug conjugates contract manufacturing are immunoglobulin g1(IGG1), and immunoglobulin g4(IGG4). Immunoglobulin G1 (IgG1) is one of the four subclasses of Immunoglobulin G (IgG), a type of antibody found in the blood and extracellular fluid. The various linkers include cleavable linkers, non-cleavable linkers with multiple conditions such as myeloma, lymphoma, and breast cancer, and others that are used in several phases such as clinical, and commercial.

Antibody Drug Conjugates Contract Manufacturing Market Segmentation

The antibody drug conjugates contract manufacturing market covered in this report is segmented –

1) By Type: Immunoglobulin G1(Igg1), Immunoglobulin G4(Igg4)

2) By Linker: Cleavable Linker, Non-Cleavable Linker

3) By Condition: Myeloma, Lymphoma, Breast Cancer, Other Conditions

4) By Phase: Clinical, Commercial

Global Antibody Drug Conjugates Contract Manufacturing Market Size 2023 to 2028: Graph

Antibody Drug Conjugates Contract Manufacturing Market Size 2024 And Growth Rate

The antibody drug conjugates contract manufacturing market size has grown strongly in recent years. It will grow from $8.72 billion in 2023 to $9.57 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of cancer, growing demand for targeted therapies, improvements in antibody drug conjugates, rising investment in research and development, regulatory approvals of new ADCs, and the expansion of pharmaceutical companies.

Antibody Drug Conjugates Contract Manufacturing Market Growth Forecast

The antibody drug conjugates contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $14.00 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to anticipated growth of personalized medicine, expanding applications beyond oncology, increasing collaborations between biotech and pharma companies, rising adoption of ADCs in clinical trials, growing emphasis on cost-effective manufacturing solutions. Major trends in the forecast period include advancements in biomarker identification, advancements in biotechnology, rising adoption of next-generation ADC technologies, advancements in linker and payload technologies, integration of artificial intelligence for drug development.

Antibody Drug Conjugates Contract Manufacturing Market Driver: Rising Biopharmaceutical Industry Fuels Growth In Antibody Drug Conjugates Contract Manufacturing Market

The growing biopharmaceutical industry is expected to propel the growth of the antibody-drug conjugates contract manufacturing market going forward. The biopharmaceutical industry is a sector focused on developing, producing, and commercializing drugs derived from biological sources, utilizing biotechnology and molecular biology to create innovative therapies and treatments. The biopharmaceutical industry is increasing due to rapid advancements in biotechnology, growing demand for personalized medicine, and rising investments in research and development for innovative therapies and treatments. Antibody-drug conjugates (ADCs) contract manufacturing supports the biopharmaceutical industry by offering specialized production services that facilitate developing and commercializing these advanced therapies. Biopharmaceutical companies can efficiently scale up production and ensure high-quality standards while concentrating on their core areas of research and development. For instance, in May 2024, according to the Department of Health and Social Care, a UK-based government department, the core biopharmaceutical sector earned £46.7 billion ($59.32 billion) in revenue in 2021/22, accounting for 43% of the whole life sciences industry. Therefore, the growing biopharmaceutical industry drives the growth of the antibody-drug conjugates contract manufacturing market.

Global Antibody Drug Conjugates Contract Manufacturing Market Major Players

Major companies operating in the antibody drug conjugates contract manufacturing market are AbbVie Inc., Eli Lilly and Company, Gilead Sciences Inc., Merck KGaA, Boehringer Ingelheim, Recipharm AB, Sigma-Aldrich, Sartorius AG, Curia, Lonza Group AG, Catalent Inc., KBI Biopharma, Alcami Corporation, Formosa Laboratories, BioVectra Inc., Axplora, Abzena PLC,  ImmunoGen Inc., EirGenix Inc., Avid Bioservices Inc., Mersana Therapeutics, Cerbios-Pharma SA, Creative Biolabs, Aurigene Pharmaceutical Services Ltd., Sterling Pharma Solutions

Global Antibody Drug Conjugates Contract Manufacturing Market Trend: Innovative Mobius ADC Reactor To Enhance Antibody-Drug Conjugate Manufacturing

Major companies operating in the antibody-drug conjugates contract manufacturing market are focused on developing innovative products, such as single-use reactors, to enhance production flexibility, reduce contamination risks, and streamline the manufacturing process, ultimately improving the efficiency and scalability of ADC production. Single-use reactors are revolutionizing the field of antibody-drug conjugates (ADCs) contract manufacturing by providing a flexible, efficient, and contamination-free solution for producing these complex biologics. For instance, in September 2024, MilliporeSigma, a US-based life science company, launched the Mobius ADC Reactor, a single-use reactor. Mobius ADC Reactor is specifically designed to manufacture antibody-drug conjugates (ADCs) efficiently. The Mobius ADC Reactor integrates advanced mixing and control technologies that streamline conjugation, enhance scalability, and improve consistency. This innovative reactor supports higher yields and better quality control in ADC production, addressing the growing demand for targeted cancer therapies with improved safety and efficacy.

Antibody Drug Conjugates Contract Manufacturing Market Merger And Acquisition: Johnson & Johnson Acquired Ambrx Biopharma To Strengthen ADC And Biologics Capabilities

In March 2024, Johnson & Johnson, a US-based pharmaceutical, biotechnology, and medical technologies corporation, acquired Ambrx Biopharma Inc. for $2.0 billion. With this acquisition, Johnson & Johnson aims to enhance its pipeline of advanced therapies by integrating Ambrx's innovative drug development technologies and expanding its biologics and targeted treatment capabilities. Ambrx Biopharma Inc. is a US-based biotechnology company that focuses on developing cutting-edge therapies, including antibody-drug conjugates (ADCs).

Regional Insights For The Global Antibody Drug Conjugates Contract Manufacturing Market

North America was the largest region in the antibody drug conjugates contract manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody drug conjugates contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibody drug conjugates contract manufacturing market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antibody drug conjugates contract manufacturing market includes revenues earned by entities by providing process development, scale-up and manufacturing, analytical testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The antibody-drug conjugates contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides antibody-drug conjugates contract manufacturing market statistics, including antibody-drug conjugates contract manufacturing industry global market size, regional shares, competitors with an antibody-drug conjugates contract manufacturing market share, detailed antibody-drug conjugates contract manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the antibody-drug conjugates contract manufacturing industry. This antibody-drug conjugates contract manufacturing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Antibody Drug Conjugates Contract Manufacturing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2024 $9.57 billion
Revenue Forecast In 2033 $14.00 billion
Growth Rate CAGR of 10.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Immunoglobulin G1(Igg1); Immunoglobulin G4(Igg
4)
2) By Linker: Cleavable Linker; Non-Cleavable Linker
3) By Condition: Myeloma; Lymphoma; Breast Cancer; Other Conditions
4) By Phase: Clinical; Commercial
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AbbVie Inc., Eli Lilly and Company, Gilead Sciences Inc., Merck KGaA, Boehringer Ingelheim, Recipharm AB, Sigma-Aldrich, Sartorius AG, Curia, Lonza Group AG, Catalent Inc., KBI Biopharma, Alcami Corporation, Formosa Laboratories, BioVectra Inc., Axplora, Abzena PLC,  ImmunoGen Inc., EirGenix Inc., Avid Bioservices Inc., Mersana Therapeutics, Cerbios-Pharma SA, Creative Biolabs, Aurigene Pharmaceutical Services Ltd., Sterling Pharma Solutions
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Antibody Drug Conjugates Contract Manufacturing Market Characteristics

    3. Antibody Drug Conjugates Contract Manufacturing Market Trends And Strategies

    4. Antibody Drug Conjugates Contract Manufacturing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Antibody Drug Conjugates Contract Manufacturing Market Size and Growth

    5.1. Global Antibody Drug Conjugates Contract Manufacturing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Antibody Drug Conjugates Contract Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Antibody Drug Conjugates Contract Manufacturing Market Segmentation

    6.1. Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Immunoglobulin G1(Igg1)

    Immunoglobulin G4(Igg4)

    6.2. Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Cleavable Linker

    Non-Cleavable Linker

    6.3. Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Myeloma

    Lymphoma

    Breast Cancer

    Other Conditions

    6.4. Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Clinical

    Commercial

    7. Antibody Drug Conjugates Contract Manufacturing Market Regional And Country Analysis

    7.1. Global Antibody Drug Conjugates Contract Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Antibody Drug Conjugates Contract Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market

    8.1. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Antibody Drug Conjugates Contract Manufacturing Market

    9.1. China Antibody Drug Conjugates Contract Manufacturing Market Overview

    9.2. China Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Antibody Drug Conjugates Contract Manufacturing Market

    10.1. India Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Antibody Drug Conjugates Contract Manufacturing Market

    11.1. Japan Antibody Drug Conjugates Contract Manufacturing Market Overview

    11.2. Japan Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Antibody Drug Conjugates Contract Manufacturing Market

    12.1. Australia Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Antibody Drug Conjugates Contract Manufacturing Market

    13.1. Indonesia Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Antibody Drug Conjugates Contract Manufacturing Market

    14.1. South Korea Antibody Drug Conjugates Contract Manufacturing Market Overview

    14.2. South Korea Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Antibody Drug Conjugates Contract Manufacturing Market

    15.1. Western Europe Antibody Drug Conjugates Contract Manufacturing Market Overview

    15.2. Western Europe Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Antibody Drug Conjugates Contract Manufacturing Market

    16.1. UK Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Antibody Drug Conjugates Contract Manufacturing Market

    17.1. Germany Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Antibody Drug Conjugates Contract Manufacturing Market

    18.1. France Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Antibody Drug Conjugates Contract Manufacturing Market

    19.1. Italy Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Antibody Drug Conjugates Contract Manufacturing Market

    20.1. Spain Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Antibody Drug Conjugates Contract Manufacturing Market

    21.1. Eastern Europe Antibody Drug Conjugates Contract Manufacturing Market Overview

    21.2. Eastern Europe Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Antibody Drug Conjugates Contract Manufacturing Market

    22.1. Russia Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Antibody Drug Conjugates Contract Manufacturing Market

    23.1. North America Antibody Drug Conjugates Contract Manufacturing Market Overview

    23.2. North America Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Antibody Drug Conjugates Contract Manufacturing Market

    24.1. USA Antibody Drug Conjugates Contract Manufacturing Market Overview

    24.2. USA Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Antibody Drug Conjugates Contract Manufacturing Market

    25.1. Canada Antibody Drug Conjugates Contract Manufacturing Market Overview

    25.2. Canada Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Antibody Drug Conjugates Contract Manufacturing Market

    26.1. South America Antibody Drug Conjugates Contract Manufacturing Market Overview

    26.2. South America Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Antibody Drug Conjugates Contract Manufacturing Market

    27.1. Brazil Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Antibody Drug Conjugates Contract Manufacturing Market

    28.1. Middle East Antibody Drug Conjugates Contract Manufacturing Market Overview

    28.2. Middle East Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Antibody Drug Conjugates Contract Manufacturing Market

    29.1. Africa Antibody Drug Conjugates Contract Manufacturing Market Overview

    29.2. Africa Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Antibody Drug Conjugates Contract Manufacturing Market Competitive Landscape And Company Profiles

    30.1. Antibody Drug Conjugates Contract Manufacturing Market Competitive Landscape

    30.2. Antibody Drug Conjugates Contract Manufacturing Market Company Profiles

    30.2.1. AbbVie Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Eli Lilly and Company

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Gilead Sciences Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck KGaA

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Boehringer Ingelheim

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Antibody Drug Conjugates Contract Manufacturing Market Other Major And Innovative Companies

    31.1. Recipharm AB

    31.2. Sigma-Aldrich

    31.3. Sartorius AG

    31.4. Curia

    31.5. Lonza Group AG

    31.6. Catalent Inc.

    31.7. KBI Biopharma

    31.8. Alcami Corporation

    31.9. Formosa Laboratories

    31.10. BioVectra Inc.

    31.11. Axplora

    31.12. Abzena PLC

    31.13.  ImmunoGen Inc.

    31.14. EirGenix Inc.

    31.15. Avid Bioservices Inc.

    32. Global Antibody Drug Conjugates Contract Manufacturing Market Competitive Benchmarking

    33. Global Antibody Drug Conjugates Contract Manufacturing Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Antibody Drug Conjugates Contract Manufacturing Market

    35. Antibody Drug Conjugates Contract Manufacturing Market Future Outlook and Potential Analysis

    35.1 Antibody Drug Conjugates Contract Manufacturing Market In 2028 - Countries Offering Most New Opportunities

    35.2 Antibody Drug Conjugates Contract Manufacturing Market In 2028 - Segments Offering Most New Opportunities

    35.3 Antibody Drug Conjugates Contract Manufacturing Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Antibody Drug Conjugates Contract Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Antibody Drug Conjugates Contract Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: AbbVie Inc. Financial Performance
  • Table 76: Eli Lilly and Company Financial Performance
  • Table 77: Gilead Sciences Inc.  Financial Performance
  • Table 78: Merck KGaA Financial Performance
  • Table 79: Boehringer Ingelheim Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Antibody Drug Conjugates Contract Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Antibody Drug Conjugates Contract Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Linker, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Antibody Drug Conjugates Contract Manufacturing Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: AbbVie Inc. Financial Performance
  • Figure 76: Eli Lilly and Company Financial Performance
  • Figure 77: Gilead Sciences Inc.  Financial Performance
  • Figure 78: Merck KGaA Financial Performance
  • Figure 79: Boehringer Ingelheim Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the antibody drug conjugates contract manufacturing market?

Antibody-drug conjugates (ADC) contract manufacturing refers to the outsourced production services provided by specialized contract development and manufacturing organizations (CDMOs) to create antibody-drug conjugates. ADCs are complex biopharmaceuticals that combine an antibody with a cytotoxic drug, designed to target and destroy specific cancer cells while minimizing damage to healthy cells. For further insights on the antibody drug conjugates contract manufacturing market, request a sample here

How will the antibody drug conjugates contract manufacturing market drivers and restraints affect the antibody drug conjugates contract manufacturing market dynamics? What forces will shape the antibody drug conjugates contract manufacturing industry goin

The antibody drug conjugates contract manufacturing market major growth driver - Rising Biopharmaceutical Industry Fuels Growth In Antibody Drug Conjugates Contract Manufacturing Market. For further insights on the antibody drug conjugates contract manufa request a sample here

What is the forecast market size or the forecast market value of the antibody drug conjugates contract manufacturing market?

The antibody drug conjugates contract manufacturing market size has grown strongly in recent years. It will grow from $8.72 billion in 2023 to $9.57 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of cancer, growing demand for targeted therapies, improvements in antibody drug conjugates, rising investment in research and development, regulatory approvals of new ADCs, and the expansion of pharmaceutical companies. The antibody drug conjugates contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $14.00 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to anticipated growth of personalized medicine, expanding applications beyond oncology, increasing collaborations between biotech and pharma companies, rising adoption of ADCs in clinical trials, growing emphasis on cost-effective manufacturing solutions. Major trends in the forecast period include advancements in biomarker identification, advancements in biotechnology, rising adoption of next-generation ADC technologies, advancements in linker and payload technologies, integration of artificial intelligence for drug development. For further insights on the antibody drug conjugates contract manufacturing market, request a sample here

How is the antibody drug conjugates contract manufacturing market segmented?

The antibody drug conjugates contract manufacturing market is segmented
1) By Type: Immunoglobulin G1(Igg1), Immunoglobulin G4(Igg4)
2) By Linker: Cleavable Linker, Non-Cleavable Linker
3) By Condition: Myeloma, Lymphoma, Breast Cancer, Other Conditions
4) By Phase: Clinical, CommercialFor further insights on the antibody drug conjugates contract manufacturing market,
request a sample here

Which region has the largest share of the antibody drug conjugates contract manufacturing market? What are the other regions covered in the report?

North America was the largest region in the antibody drug conjugates contract manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody drug conjugates contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the antibody drug conjugates contract manufacturing market, request a sample here.

Who are the major players in the antibody drug conjugates contract manufacturing market?

Major companies operating in the antibody drug conjugates contract manufacturing market are AbbVie Inc., Eli Lilly and Company, Gilead Sciences Inc., Merck KGaA, Boehringer Ingelheim, Recipharm AB, Sigma-Aldrich, Sartorius AG, Curia, Lonza Group AG, Catalent Inc., KBI Biopharma, Alcami Corporation, Formosa Laboratories, BioVectra Inc., Axplora, Abzena PLC,  ImmunoGen Inc., EirGenix Inc., Avid Bioservices Inc., Mersana Therapeutics, Cerbios-Pharma SA, Creative Biolabs, Aurigene Pharmaceutical Services Ltd., Sterling Pharma Solutions For further insights on the antibody drug conjugates contract manufacturing market, request a sample here.

What are the key trends in the antibody drug conjugates contract manufacturing market?

Major trend in the antibody drug conjugates contract manufacturing market - Innovative Mobius ADC Reactor To Enhance Antibody-Drug Conjugate Manufacturing. For further insights on the antibody drug conjugates contract manufacturing market, request a sample here.

What are the major opportunities in the antibody drug conjugates contract manufacturing market? What are the strategies for the antibody drug conjugates contract manufacturing market?

For detailed insights on the major opportunities and strategies in the antibody drug conjugates contract manufacturing market, request a sample here.

How does the antibody drug conjugates contract manufacturing market relate to the overall economy and other similar markets?

For detailed insights on antibody drug conjugates contract manufacturing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the antibody drug conjugates contract manufacturing industry?

For detailed insights on the mergers and acquisitions in the antibody drug conjugates contract manufacturing industry, request a sample here.

What are the key dynamics influencing the antibody drug conjugates contract manufacturing market growth? SWOT analysis of the antibody drug conjugates contract manufacturing market.

For detailed insights on the key dynamics influencing the antibody drug conjugates contract manufacturing market growth and SWOT analysis of the antibody drug conjugates contract manufacturing industry, request a sample here.